Tharimmune, Inc.
Why Robinhood?
You can watch THAR and buy or sell other stocks, ETFs, and their options commission-free!About THAR
Canton Strategic Holdings, Inc. is a clinical-stage biotechnology company developing a portfolio of therapeutic candidates for inflammation and immunology. It also develops TH104, which is known to suppress chronic, debilitating pruritus or uncontrollable itching in PBC, a rare and orphan liver disease with no known cure.
THAR Key Statistics
Stock Snapshot
As of today, Tharimmune, Inc.(THAR) shares are valued at $4.74. The company's market cap stands at 268.55M, with a P/E ratio of -1.40.
During the trading day, Tharimmune, Inc.(THAR) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for Tharimmune, Inc.(THAR) stock has reached 0, versus its average volume of 590.05K.
The stock's 52-week range extends from a low of $1.08 to a high of $9.08.
The stock's 52-week range extends from a low of $1.08 to a high of $9.08.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.